PRP treatment for COPD can help reduce lung damage caused by smoking, pollution and other factors.
Respiratory diseases and lung diseases are still the most common cause of illness and mortality in Germany, despite medical advances.
Smoking, infections and genetics are responsible for most lung diseases. The lungs are part of a complex machine that expands and relaxes thousands of times a day to take in oxygen and expel carbon dioxide. Lung disease can be caused by problems in any part of this system.
COPD is a life-threatening condition and currently there is no cure for it. However, medication, steroids, breathing support and possibly surgery can relieve some of the discomfort and breathing difficulties.
More recently, PRP treatments for COPD have emerged as a potential cure for the disease. Doctors have successfully used PRP to help patients in various medical fields. And they are now looking into the possibility of giving PRP nebulisers for COPD.
The main cause of COPD disease is smoking, actively or passively
COPD can have several causes:
- Genetic predisposition
- Lung weakness Premature births that can underdevelop the lungs.
- Environmental pollution Working with dangerous chemical fumes.
- Smoking is the main cause of COPD
Chronic bronchitis causes inflammation of the airways, which reacts with excess mucus and makes breathing difficult. Emphysema is a condition where the alveoli or air sacs in the lungs are damaged to function normally. As a result, they cannot take in oxygen and release carbon dioxide and other gases into the air.
PRP treatments for COPD disease can help repair these damaged alveoli and reverse the severity of the disease.
Treatment with PRP can reverse lung damage
Platelet-rich plasma (PRP) contains various growth factors, mesenchymal stem cells, cytokines and other elements that help heal hard and soft tissue.
Once the PRP serum is made, doctors introduce it into the lungs through the PRP nebuliser. The plasma and healing factors attach to the air sacs or endothelial cells in the lungs and trigger a repair mechanism for their regeneration.
In addition, PRP treatments for COPD contain vitronectin, fibronectin and fibrin. These elements can reduce the level of inflammation and help heal the damaged lung tissue. When the swelling subsides, the lungs and airways produce less mucus and sputum. As a result, patients notice a gradual improvement in breathing.
Treatment with PRP can reverse lung damage
With the PRP nebuliser, doctors can deliver 80% of the healing cells to precise locations for the most effective results. Experienced lung doctors put PRP serum into the basic inhaler and ask patients to breathe as if they were taking steam to relieve an asthma attack. The process is simple and non-invasive, and elderly patients can easily take the inhaler.
What diseases could be treated with PRP (Platelet Rich Plasma)?
- Chronic bronchitis
- Interstitial lung disease
- Pulmonary fibrosis
PRP treatment procedure
- A small blood sample is taken from the patient using PRP tubes.
- The blood is taken and put into a centrifuge. This centrifuge spins the blood and separates it into three different layers: the platelet-poor layer, the buffy coat (which contains the platelets and white blood cells) and the red blood cells. It is this middle layer that is called PRP (platelet-rich plasma).
- PRP is minimally processed to produce a nebulised solution. The nebulised PRP concentrate is then introduced into the lungs through a nebuliser.
The concentrated cells are naturally trapped in the lung tissue where they can begin to promote healing in the lungs. The plasma adheres to the lung and triggers a healing response. This new delivery method allows the patient to breathe aerosolised particles of nebulised PRP and increase platelet flow to the endothelial surface, reducing inflammation and stimulating healing.
Then, over the course of several weeks to months, damaged tissue in the area begins to heal and is gradually replaced by new, healthy tissue. Most patients find that their chronic pain can be reduced or eliminated with one or more PRP applications.
Frequency: Doctors recommend a three-week programme with two treatments per week.
Thanks to the adaptability of Platelet Rich Plasma (PRP) to other therapies and techniques, COPD patients can now find a solution to their condition. Following new clinical trials to confirm the results, doctors may be able to treat more patients in the future.